CAUTION: WHAT YOU DISCLOSE ONLINE ABOUT YOUR HEALTH IS NOT PROTECTED BY HIPA REGULATIONS.

CAUTION: WHAT YOU DISCLOSE ONLINE ABOUT YOUR HEALTH IS NOT PROTECTED BY HIPA REGULATIONS.

HIPAA rules bar "covered entities" such as medical practices and hospitals from disclosing our protected health information without first receiving our consent. But for data generated outside the covered entities, there aren't any HIPA protections. Without HIPA protection, we are primarily on our own concerning understanding how companies utilize our personal and health data when we are on social media.

Analysis Finds Timing of ADT with Radiation Impacts Outcomes in Localized Prostate Cancer

Analysis Finds Timing of ADT with Radiation Impacts Outcomes in Localized Prostate Cancer

ADT sequencing significantly impacted clinical outcomes with a strong correlation to radiation therapy field size. Concurrent and adjuvant ADT should be the standard of care where short-term ADT is indicated in combination with prostate radiation.

Obtaining Mental Health Services When You Have Cancer

Obtaining Mental Health Services When You Have Cancer

At Cancer ABCs, we understand that cancer diagnosis and treatment are emotionally draining for all. Depression and anxiety are more prevalent in the cancer community, which often impacts treatment outcomes. Depression, anxiety, and fear can make it difficult for patients to participate in therapy, adhere to treatment regimens, and even participate in life. Patients facing mental health issues may have difficulty maintaining a healthy lifestyle, impacting how well cancer therapies work.

A New Standard of Care After Prostate Surgery

A New Standard of Care After Prostate Surgery

The standard of care has been to treat only the prostate surgery bed. The SPPORT study (RTOG/NRG Oncology 0534) was designed to see if adding short-term hormone therapy or short-term hormone therapy plus pelvic lymph node radiation significantly lowers recurrence and the risk of cancer spreading.

Hormone Therapy Plus Radiotherapy Improves Survival in Men with Localized Prostate Cancer

Hormone Therapy Plus Radiotherapy Improves Survival in Men with Localized Prostate Cancer

findings provide the strongest evidence so far to the magnitude of thesurvival benefit of ADT treatment intensification with radiotherapy for men with localized prostate cancer

To Radiate After Surgery, That Is The Question

To Radiate After Surgery, That Is The Question

The trials have concluded that routinely giving post-surgical radiation does not improve outcomes after five years compared with giving radiation only if the prostate specific antigen (PSA) blood test signals a cancer recurrence.

Vascular-Targeted Photodynamic Therapy (VTP) Reduces Disease Progression In Low-Risk Prostate Cancer

Vascular-Targeted Photodynamic Therapy (VTP) Reduces Disease Progression In Low-Risk Prostate Cancer

After five years, a higher proportion of the participating men in the active surveillance group (68%) were found to experience a disease progression event compared with the VTP-treated patients (38%).

The median time to disease progression of 13.8 months among men in the active surveillance arm, but in the VTM arm, there is still has not been a period reached.

Prazosin Might Reduce the Risk of Biochemical Recurrence of Prostate Cancer Following Radiotherapy

Prazosin Might Reduce the Risk of Biochemical Recurrence of Prostate Cancer Following Radiotherapy

The drug Prazosin is sometimes used to manage lower urinary tract symptoms (LUTS) experienced by men receiving radiotherapy for localized prostate cancer. There is evidence that some alpha1-adrenoceptor antagonists such as Prazosin reduce prostate cancer incidence and increase apoptosis in the prostate. A study also demonstrated that these drugs can reduce the recurrence rate of prostate cancer in men having radiotherapy.

Radiation Therapy During COVID-19 Pandemic

Radiation Therapy During COVID-19 Pandemic

A panel of top radiation oncologists in the US and the UK has addressed the question of putting off or shortening various kinds of radiation treatment (RT) for prostate cancer at a time when it is best to maintain distance from institutions that treat patients.